Paeds Vivas · genetics-dysmorphology-and-metabolism
Williams syndrome — branching viva
Branching viva on Williams syndrome: recognising the multisystem pattern of the 7q11.23 microdeletion, explaining the ELN-driven elastin arteriopathy and coronary risk, confirming the deletion with chromosomal microarray, managing infantile hypercalcaemia, and counselling the autosomal dominant inheritance.
On this page
Study tools
Target exams
Opening framework
My framework has four layers. First, the pattern — a dysmorphic infant with a murmur, hypertension, and metabolic disturbance points to a contiguous-gene microdeletion syndrome. Second, the gene — the cardiovascular phenotype is driven by ELN haploinsufficiency, producing an elastin arteriopathy. Third, the test — a chromosomal microarray confirms the 7q11.23 deletion. Fourth, the family — the deletion is autosomal dominant, so a parent who carries it confers a 50 percent recurrence risk. [1] [2]
References6ShowHide
- [1]Morris CA, et al. Health Care Supervision for Children With Williams Syndrome. Pediatrics, 2020.PMID 31964759
- [2]Kozel BA, et al. Williams syndrome. Nat Rev Dis Primers, 2021.PMID 34140529
- [3]Collins RT 2nd. Cardiovascular disease in Williams syndrome. Curr Opin Pediatr, 2018.PMID 30045083
- [5]Merla G, et al. Supravalvular aortic stenosis: elastin arteriopathy. Circ Cardiovasc Genet, 2012.PMID 23250899
- [6]Sindhar S, et al. Hypercalcemia in Patients with Williams-Beuren Syndrome. J Pediatr, 2016.PMID 27574996
- [7]Twite MD, Stenquist S, Ing RJ Williams syndrome. Paediatr Anaesth, 2019.PMID 30811742